- Contact for pricing
- Not disclosed
- Not disclosed
- —
- —
- IL
Radiology
MaxQ AI Accipio
by MaxQ AI · IL
Accipio flagged suspected intracranial haemorrhage on head CT. MaxQ AI stopped operations in January 2022 and discontinued it.
On this page
Accipio flagged suspected intracranial haemorrhage on head CT. MaxQ AI stopped operations in January 2022 and discontinued it.
Contact for pricing.
Bottom line
Accipio was an AI tool from the Israeli company MaxQ AI that flagged suspected intracranial haemorrhage on non-contrast head CT and moved those scans up the worklist. The Imaging Wire reported in January 2022 that MaxQ AI stopped commercial operations, and AuntMinnie reported that the company was discontinuing Accipio and ending its image-analysis AI work.
What was Accipio?
AuntMinnie describes Accipio as software for detecting and triaging intracranial haemorrhage, also called ICH, on head CT. MaxQ later launched a second-generation Accipio clinical platform, announced through PRWeb. Versions called Accipio Ix and Ax were offered on the Nuance AI Marketplace, and the product was also distributed through the Blackford platform from December 2019.
What did the FDA clear?
The FDA's 510(k) records list two clearances for the product under the applicant name Maxq-Al, Ltd., both for the device listed as Accipiolx in product code QAS:
- K182177, October 2018
- K201310, August 2020
What happened to the company?
The Imaging Wire framed the January 2022 shutdown, which came with layoffs of sales and marketing staff, as an opening for competing ICH products, and named Qure.ai, Aidoc and Avicenna.ai as rivals that benefited. It also reported that neither Qure.ai nor Nuance acquired MaxQ.
The verdict
Accipio was cleared in October 2018 and again in August 2020, and was discontinued in early 2022.
Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What deploys cleanly
Carries FDA 510(k) per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.
Other radiology
See the full radiology ranking
Siemens Healthineers AI-Rad Companion
by Siemens Healthineers
AI-Rad Companion: Chest CT, Chest X-ray, Brain MR, Prostate MR and Organs RT (radiotherapy contouring) modules, delivered through teamplay.
No public price on the vendor page.|FDA 510(k) (multiple) / CE Mark (MDD/MDR. MDR status not verified)
GE HealthCare AI Suite
by GE HealthCare
Portfolio of separately cleared AI-enabled GE HealthCare devices and software, including AIR Recon DL, Sonic DL, Critical Care Suite, Caption AI and icobrain.
No public price. Products are sold with scanners or as scanner options, on enterprise quotes.|FDA 510(k) (multiple)
Aidoc
by Aidoc
Clinical AI platform (aiOS) with FDA-cleared triage, notification and quantification algorithms for radiology and neurovascular care.
Private offer only. No trial is stated.|FDA 510(k) (multiple) / EU MDR 2017/745
Viz.ai
by Viz.ai
Care coordination platform with FDA-cleared imaging AI for stroke, vascular and cardiac conditions.
No public price. Sold to health systems after a demo request.|FDA 510(k) (multiple) / FDA De Novo (ContaCT, Viz HCM)